About Upside Foods
Upside Foods was founded in 2015 by Uma Valeti, a cardiologist, along with Nicholas Genovese, pursuing cultivated meat technology, sometimes called cultured or lab-grown meat, which involves growing genuine animal muscle and fat cells directly in a controlled bioreactor environment to produce actual meat without raising and slaughtering a live animal, a technology aimed at producing meat that the company argues is molecularly identical to conventionally produced meat, with the potential for a significantly smaller environmental footprint and without the animal welfare concerns some consumers associate with traditional animal agriculture, though the technology has faced significant technical and economic challenges achieving production costs and scale competitive with conventional meat production.
The company's production process begins with cells obtained from a living animal through a biopsy, without requiring the animal's slaughter, which are then grown and multiplied in large bioreactor vessels under controlled conditions that support the cells' natural growth and differentiation into muscle and fat tissue, eventually producing a meat product the company has argued is genuinely equivalent to conventionally raised meat in composition and, ideally, taste and texture, though achieving fully equivalent taste, texture, and production cost at meaningful commercial scale has remained a significant ongoing technical and economic challenge across the cultivated meat industry broadly. Upside Foods achieved a significant industry milestone in 2023 when it received approval from the U.S. Department of Agriculture and Food and Drug Administration to sell its cultivated chicken product to consumers, making it one of the first companies globally, alongside competitor Eat Just's GOOD Meat subsidiary, to receive regulatory clearance for cultivated meat sales in the United States, though the company has continued facing the substantial challenge of scaling production to commercially meaningful volumes at costs competitive with conventional chicken, a milestone that has proven more difficult and capital-intensive across the cultivated meat industry than many companies initially projected when the sector attracted significant investor enthusiasm in earlier years. Upside Foods has raised very substantial venture funding from investors including Tyson Foods, Cargill, and SoftBank Group, reaching a valuation exceeding $1 billion, positioning itself among the most prominent companies in the developing cultivated meat industry.
